Industry should improve the standards on application of risk management tools in light of the cases of nitrosamine impurities.
Niamh Panesar
Advertisement
Niamh Panesar is CMC senior manager at Kinapse Ltd, UK.
Articles by Niamh Panesar
Advertisement
Latest Updated Articles
Nitrosamine Impurities in Medicinal ProductsPublished: December 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of November 3, 2025
2
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
2025 AAPS PharmSci 360 to Highlight Next-Gen AI for Drug Development
5
